Purinergic Signal
Purinergic Signalling
1573-9538
1573-9546
Springer Netherlands
Dordrecht


2096766
18404431
9050
10.1007/s11302-006-9050-y
Original Paper


CD39 and control of cellular immune responses

Dwyer
Karen M.

1

Deaglio
Silvia

2

Gao
Wenda

3

Friedman
David

3

Strom
Terry B.

3

Robson
Simon C.

+1-617-6321861
srobson@bidmc.harvard.edu

3

1
Immunology Research Centre, St. Vincent’s Health, Melbourne, Australia 
2
Laboratorio di Immunogenetica, University of Turin, Turin, Italy 
3
Transplant Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215 USA 

6
2
2007

3
2007

3
1-2
171
180
30
11
2006

5
12
2006


© Springer Science + Business Media B.V. 2007

Cd39
-null mice that spontaneously develop features of autoimmune diseases associated with Th1 immune deviation. These data indicate the potential of CD39 and modulated purinergic signalling in the co-ordination of immunoregulatory functions of dendritic and Treg cells. Our findings also suggest novel therapeutic strategies for immune-mediated diseases.

Keywords
Apyrase
B cells
CD39
Dendritic cells
Ecto-ATPase
E-NTPD
Immunology
Kidney
Liver
NTPDase
Platelet
T cells
Vasculature

issue-copyright-statement
© Springer Science + Business Media B.V. 2007




Introduction
1
2
3
+
+
4
4
6
7
8
9
10
]. Primary release of the mediator could occur ab initio, or this might follow conversion of released nucleotides to adenosine (see later).
11
12
11
12
9
13
].
2
14
]. These ecto-enzymes hydrolyze extracellular nucleotides to generate nucleosides that in turn activate adenosine receptors, often with opposing effects to those seen with P2-mediated effects. Within the past decade, ecto-nucleotidases belonging to several enzyme families have been discovered, cloned and functionally characterized by pharmacological means.
15
16
2
17
2
2
].
Purinergic Signalling
 entitled ‘Ecto-nucleotidases–(PUSI 2, 2: 2006). This review will address only the immunobiology of CD39, focusing on T lymphocytes and alluding briefly to co-expression of CD73 by immunosuppressive T cell subsets.

CD39 in the immune system
1
18
19
]. The relevance of the expression of CD39 by these cells is not yet clear.
Cd39
CD39
20
21
Cd39
20
Cd39
14
Cd39
Cd39
-null mice exhibit impaired B cell memory responses to T-dependent antigens. Unexpectedly, however, these mutant mice show a significant increase in the frequency of somatic mutations post-immunization (not shown). These observations suggest that CD39 function may contribute to the affinity maturation of antibody responses and to facilitate post-germinal center terminal B cell differentiation (M. Cascalho et al., manuscript in preparation).
19
]; G. Beldi, unpublished), the relevance of this has not yet been fully elucidated.
Cd39
22
23
Cd39
20
Cd39
Cd39
Cd39
14
24
].
25
26
27
].
Cd39
28
Cd39
28
].
Cd39
Cd39
-null mice, there are major defects in dendritic cell formation, antigen presentation and T cell responses to haptens. These result in markedly attenuated responses to contact allergens in type IV hypersensitivity cutaneous responses that are also seen in inflammatory bowel disease models following haptenic stimulation (not shown).
Cd39
28
29
Cd39
14
Cd39
30
28
].
31
32
Cd39
33
36
]. CD39 on DC and/or T cells may be likewise translocated to the immunological synapse during antigen presentation to facilitate intercellular signalling. More typically, CD39 is considered to play a cellular immunoregulatory role by hydrolyzing ATP (and perhaps ADP) released by T cells during antigen presentation and thereby generating adenosine, a known immunosuppressive molecule.
37
38
]. Patterns of expression of CD39 by Treg and the possibility that the balance of extracellular nucleotides/nucleosides influence(s) the function of these interesting cells have been a major focus of investigation in our laboratories of late.

CD39 expression by immunosuppressive regulatory T cells
39
33
40
].
+
+
+
41
].
42
].
Cd39
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
43
].
+
+
+
+
+
1
+
+
+
1
+
high
+
dim
+
+
−
+
+
low
low
Fig. 1
a
+
open profiles
gray profiles
+
b
+
+
+
-
-
+
-
-
+
+
striped bars
c
+
+
+
-
-
+
-
-
+
striped bars
-
+
 subset does not express CD73 and these cells resemble the memory phenotype (not shown)




+
+
+
+
+
+
+
−
40
+
+
+
−
+
+
 Treg (S. Deaglio et al., submitted manuscript).
+
+
+
+
high
+
+
dim
+
−
+
+
+
+
+
+
 cells that expresses markers associated with T regulatory function.
+
+
44
+
+
+
−
−
+
−
−
+
+
1
–
+
1
b).
+
+
1
+
+
1
+
+
−
42
1
c).

Adenosine as a Treg effector molecule
Cd39
2
Fig. 2
+
+
+
 expression. Phosphohydrolysis of extracellular nucleotides by CD39 and CD73 generates adenosine, which exerts a component of the immunosuppressive effect




9
10
45
9
10
28
46
].
47
+
+
−
) T cells, generates immunosuppressive loops limiting effector cell proliferation both in vitro and in vivo (S. Deaglio et al., submitted).

Cd39
-null mice
48
49
Cd39
+
 T cells were polarized to a Th1 or Th2 phenotype through the addition of IL-12 (10 ng/ml) and anti-IL-4 (10 μg/ml) or IL-4 (10 ng/ml) and anti-IFN-γ (10 μg/ml), respectively, following stimulation with plate-bound anti-CD3 (5 μg/ml) and soluble anti-CD28 (2.5 μg/ml). The polarization of cells was confirmed by intracellular cytokine staining and gene profiling via RT-PCR analysis.
+
−
9
50
3
Fig. 3
a
+
error bars
b
+
Cd39
filled histograms
open histograms
left panel
c
+
Cd39
filled histograms
open histograms
left panel
d
Cd39
+
e
Cd39
upper panel
lower panel
Cd39
f
Cd39
-null mice affected by alopecia, the tissue homogenized and mRNA extracted. Cytokine profiling was performed by RT-PCR, using a preamplification technique. Uninvolved skin from the same animal or a matched WT mouse used as controls. Representative data are from three animals




+
Cd39
3
50
Cd39
Cd39
3
3
Cd39
3
d).
Cd39
Cd39
3
Cd39
3
+
+
3
3
3
f). Autoimmune manifestations impacting other organ systems and on renal function are under evaluation (D. Friedman, not shown).
These data validate the importance of adenosine in directing T cell subset differentiation and support a role for CD39 in orchestrating Treg cell suppressive responses under both in vitro and in vivo conditions.

Summation
This review summarizes components of extracellular nucleotide-mediated signalling pathway in T cells that are impacted upon largely by CD39, the prototypic member of the E-NTPDase family of ecto-nucleotidases. Modulated, distinct NTPDase expression appears to regulate nucleotide- and nucleoside-mediated signalling in the immune system. As the vasculature uses similar mediators to regulate blood fluidity and hemostasis, expression of CD39 on either endothelial or immune cells might allow for full integration of vascular inflammatory and immune cell reactions at sites of injury.
There is a wide field for future investigations of the role of nucleotides, nucleosides and ecto-nucleotidases in immune-mediated diseases. Increasing interest in this field may open up new avenues for investigation and the development of new treatment modalities for a large variety of illnesses, including atherosclerosis and the vascular or immune inflammation seen in transplant-related diseases.


Acknowledgements
SCR acknowledges grant support from NIH HL57307, HL63972 and HL076540. Mutant mice with the green fluorescent protein (GFP) reporter gene introduced into the endogenous Foxp3 locus were kindly provided by M. Oukka and V. K. Kuchroo, Boston, MA, USA. ATL146e was a kind gift of J. Linden, Adenosine Therapeutics, Charlottesville, VA, USA.

References
1.
Robson
SC

Wu
Y

Sun
X

Knosalla
C

Dwyer
K

Enjyoji
K


Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation
Semin Thromb Hemost
2005
31
217
233
10.1055/s-2005-869527

15852225


2.
Robson
SC

Sevigny
J

Zimmermann
H


The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance
Purinergic Signalling
2006
2
409
430
10.1007/s11302-006-9003-5

18404480


3.
Luthje
J


Origin, metabolism and function of extracellular adenine nucleotides in the blood [published erratum appears in Klin Wochenschr (1989) 67(10):558]
Klin Wochenschr
1989
67
317
327
10.1007/BF01741386

2651791


4.
la Sala
A

Ferrari
D

Di Virgilio
F

Idzko
M

Norgauer
J

Girolomoni
G


Alerting and tuning the immune response by extracellular nucleotides
J Leukoc Biol
2003
73
339
343
10.1189/jlb.0802418

12629147


5.
Imai
M

Goepfert
C

Kaczmarek
E

Robson
SC


CD39 modulates IL-1 release from activated endothelial cells
Biochem Biophys Res Commun
2000
270
272
278
10.1006/bbrc.2000.2410

10733939


6.
Warny
M

Aboudola
S

Robson
SC

Sevigny
J

Communi
D

Soltoff
SP

Kelly
CP


P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide
J Biol Chem
2001
276
26051
26056
10.1074/jbc.M102568200

11349132


7.
Sala
A

Ferrari
D

Corinti
S

Cavani
A

Virgilio
F

Girolomoni
G


Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses
J Immunol
2001
166
1611
1617

11160202


8.
Ogura
Y

Sutterwala
FS

Flavell
RA


The inflammasome: first line of the immune response to cell stress
Cell
2006
126
659
662
10.1016/j.cell.2006.08.002

16923387


9.
Sitkovsky
MV

Lukashev
D

Apasov
S

Kojima
H

Koshiba
M

Caldwell
C

Ohta
A

Thiel
M


Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors
Annu Rev Immunol
2004
22
657
682
10.1146/annurev.immunol.22.012703.104731

15032592


10.
Sitkovsky
M

Lukashev
D


Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors
Nat Rev Immunol
2005
5
712
721
10.1038/nri1685

16110315


11.
Burnstock
G

Knight
G


Cellular distribution and functions of P2 receptor subtypes in different systems
Int Rev Cytol
2004
240
31
304
10.1016/S0074-7696(04)40002-3

15548415


12.
Burnstock
G


Purinergic signaling and vascular cell proliferation and death
Arterioscler Thromb Vasc Biol
2002
22
364
373
10.1161/hq0302.105360

11884276


13.
Koshiba
M

Kojima
H

Huang
S

Apasov
S

Sitkovsky
MV


Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells
J Biol Chem
1997
272
25881
25889
10.1074/jbc.272.41.25881

9325320


14.
Robson
SC

Enjyoji
K

Goepfert
C

Imai
M

Kaczmarek
E

Lin
Y

Sevigny
J

Warny
M


Modulation of extracellular nucleotide-mediated signaling by CD39/nucleoside triphosphate diphosphohydrolase-1
Drug Dev Res
2001
53
193
207
10.1002/ddr.1188

Robson SC, Enjyoji K, Goepfert C, Imai M, Kaczmarek E, Lin Y, Sevigny J, Warny M (2001) Modulation of extracellular nucleotide-mediated signaling by CD39/nucleoside triphosphate diphosphohydrolase-1. Drug Dev Res 53:193–07 

15.
Kaczmarek
E

Koziak
K

Sevigny
J

Siegel
JB

Anrather
J

Beaudoin
AR

Bach
FH

Robson
SC


Identification and characterization of CD39 vascular ATP diphosphohydrolase
J Biol Chem
1996
271
33116
33122
10.1074/jbc.271.51.33116

8955160


16.
Zimmermann H, Braun N, Heine P, Kohring K, Sevigny J, Robson SC (2000) Molecular and functional properties of E-NTPDase-1, E-NTPDase-2 and 5–ectonucleotidase. Proceedings of the Second International Workshop on Ecto-ATPases and Related Ectonucleotidases. In: Vanduffel L (ed). Shaker Publishing BV, Maastricht, The Netherlands, pp 18–5

17.
Resta
R

Yamashita
Y

Thompson
LF


Ecto-enzyme and signaling functions of lymphocyte CD73
Immunol Rev
1998
161
95
109
10.1111/j.1600-065X.1998.tb01574.x

9553767


18.
Maliszewski
CR

Delespesse
GJ

Schoenborn
MA

Armitage
RJ

Fanslow
WC

Nakajima
T

Baker
E

Sutherland
GR

Poindexter
K

Birks
C



The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization
J Immunol
1994
153
3574
3583

7930580


19.
Koziak
E

Sevigny
J

Robson
SC

Siegel
JB

Kaczmarek
K


Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes
Thromb Haemost
1999
82
1538
1544

10595651


20.
Enjyoji
K

Sevigny
J

Lin
Y

Frenette
PS

Christie
PD

Esch
JSA

Imai
M

Edelberg
JM

Rayburn
H

Lech
M

Beeler
DL

Csizmadia
E

Wagner
DD

Robson
SC

Rosenberg
RD


Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
Nature Med
1999
5
1010
1017
10.1038/12447

10470077


21.
Dwyer
KM

Robson
SC

Nandurkar
HH

Campbell
DJ

Gock
H

Murray-Segal
LJ

Fisicaro
N

Mysore
TB

Kaczmarek
E

Cowan
PJ

d’Apice
AJ


Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation
J Clin Invest
2004
113
1440
1446

15146241


22.
Kaczmarek
E

Erb
L

Koziak
K

Jarzyna
R

Wink
MR

Guckelberger
O

Blusztajn
JK

Trinkaus-Randall
V

Weisman
GA

Robson
SC


Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways
Thromb Haemost
2005
93
735
742

15841322


23.
Weisman
GA

Griffin
K

Santiago-Perez
LI

Liu
J

Krugh
B

Flores
RV

Chorna
NE

Santos-Berrios
C

Vivas-Mejia
PE

Garrad
RC

Gonzalez
FA

Erb
L


P2Y(2) receptors regulate multiple signal transduction pathways in monocytic cells
Drug Dev Res
2001
53
186
192
10.1002/ddr.1187

Weisman GA, Griffin K, Santiago-Perez LI, Liu J, Krugh B, Flores RV, Chorna NE, Santos-Berrios C, Vivas-Mejia PE, Garrad RC, Gonzalez FA, Erb L (2001) P2Y(2) receptors regulate multiple signal transduction pathways in monocytic cells. Drug Dev Res 53:186–92 

24.
Goepfert
C

Sundberg
C

Sevigny
J

Enjyoji
K

Hoshi
T

Csizmadia
E

Robson
S


Disordered cellular migration and angiogenesis in cd39-null mice
Circulation
2001
104
3109
3115
10.1161/hc5001.100663

11748109


25.
Salmi
M

Jalkanen
S


Cell-surface enzymes in control of leukocyte trafficking
Nat Rev Immunol
2005
5
760
771
10.1038/nri1705

16200079


26.
Eltzschig
HK

Ibla
JC

Furuta
GT

Leonard
MO

Jacobson
KA

Enjyoji
K

Robson
SC

Colgan
SP


Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors
J Exp Med
2003
198
783
796
10.1084/jem.20030891

12939345


27.
Eltzschig
HK

Thompson
LF

Karhausen
J

Cotta
RJ

Ibla
JC

Robson
SC

Colgan
SP


Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism
Blood
2004
104
3986
3992
10.1182/blood-2004-06-2066

15319286


28.
Mizumoto
N

Kumamoto
T

Robson
SC

Sevigny
J

Matsue
H

Enjyoji
K

Takashima
A


CD39 is the dominant Langerhans cell associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness
Nature Med
2002
8
358
365
10.1038/nm0402-358

11927941


29.
Stockl
J

Majdic
O

Fischer
G

Maurer
D

Knapp
W


Monomorphic molecules function as additional recognition structures on haptenated target cells for HLA-A1-restricted, hapten-specific CTL
J Immunol
2001
167
2724
2733

11509616


30.
Li
Y

Csizmadia
E

Sevigny
J

Enjyoji
K

Robson
SC


CD39/nucleoside triphosphate diphosphohydrolase-1 (NTPDase-1) modulates allograft rejection and cellular immune responses
Am J Transplant Suppl
2003
3
545

Li Y, Csizmadia E, Sevigny J, Enjyoji K, Robson SC (2003) CD39/nucleoside triphosphate diphosphohydrolase-1 (NTPDase-1) modulates allograft rejection and cellular immune responses. Am J Transplant Suppl 3:545 

31.
Koziak
K

Kaczmarek
E

Kittel
A

Sevigny
J

Blusztajn
JK

Esch
JSA

Imai
M

Guckelberger
O

Goepfert
C

Qawi
I

Robson
SC


Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae
J Biol Chem
2000
275
2057
2062
10.1074/jbc.275.3.2057

10636909


32.
Shaul
PW

Anderson
RGW


Role of plasmalemmal caveolae in signal transduction
Am J Physiol
1998
275
L843
L851

9815100


33.
Dustin
ML


Stop and go traffic to tune T cell responses
Immunity
2004
21
305
314
10.1016/j.immuni.2004.08.016

15357942


34.
Tooley
AJ

Jacobelli
J

Moldovan
MC

Douglas
A

Krummel
MF


T cell synapse assembly: proteins, motors and the underlying cell biology
Semin Immunol
2005
17
65
75
10.1016/j.smim.2004.09.006

15582489


35.
Friedl
P

Storim
J


Diversity in immune-cell interactions: states and functions of the immunological synapse
Trends Cell Biol
2004
14
557
567
10.1016/j.tcb.2004.09.005

15450978


36.
Maldonado
RA

Irvine
DJ

Schreiber
R

Glimcher
LH


A role for the immunological synapse in lineage commitment of CD4 lymphocytes
Nature
2004
431
527
532
10.1038/nature02916

15386021


37.
Holm
T

Nielsson
J

Claesson
M


CD4+ and CD25+ regulatory T cells: I. Phenotype and physiology
APMIS
2004
112
629
641
10.1111/j.1600-0463.2004.apm1121001.x

15601314


38.
Shevach
EM

DiPaolo
RA

Andersson
J

Zhao
DM

Stephens
GL

Thornton
AM


The lifestyle of naturally occurring CD4+ CD25+ foxp3+ regulatory T cells
Immunol Rev
2006
212
60
73
10.1111/j.0105-2896.2006.00415.x

16903906


39.
Stassen
M

Schmitt
E

Jonuleit
H


Human CD4+CD25+ regulatory T cells and infectious tolerance
Transplantation
2004
77
S23
S25
10.1097/00007890-200401151-00009

14726765


40.
Walsh
PT

Taylor
DK

Turka
LA


Tregs and transplantation tolerance
J Clin Invest
2004
114
1398
1403

15545987


41.
Fontenot
JD

Rasmussen
JP

Williams
LM

Dooley
JL

Farr
AG

Rudensky
AY


Regulatory T cell lineage specification by the forkhead transcription factor foxp3
Immunity
2005
22
329
341
10.1016/j.immuni.2005.01.016

15780990


42.
Kobie
JJ

Shah
PR

Yang
L

Rebhahn
JA

Fowell
DJ

Mosmann
TR


T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5–adenosine monophosphate to adenosine
J Immunol
2006
177
6780
6786

17082591


43.
Sevigny
J

Sundberg
C

Braun
N

Guckelberger
O

Csizmadia
E

Qawi
I

Imai
M

Zimmermann
H

Robson
SC


Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation
Blood
2002
99
2801
2809
10.1182/blood.V99.8.2801

11929769


44.
Bettelli
E

Carrier
Y

Gao
W

Korn
T

Strom
TB

Oukka
M

Weiner
HL

Kuchroo
VK


Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells
Nature
2006
441
235
238
10.1038/nature04753

16648838


45.
Lappas
CM

Day
YJ

Marshall
MA

Engelhard
VH

Linden
J


Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation
J Exp Med
2006
203
2639
2648
10.1084/jem.20061097

17088433


46.
Zhang
N

Yang
D

Dong
H

Chen
Q

Dimitrova
DI

Rogers
TJ

Sitkovsky
M

Oppenheim
JJ


Adenosine A2A receptors induce heterologous desensitization of chemokine receptors
Blood
2006
108
38
44
10.1182/blood-2005-06-2599

16522819


47.
Takahashi
T

Kuniyasu
Y

Toda
M

Sakaguchi
N

Itoh
M

Iwata
M

Shimizu
J

Sakaguchi
S


Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state
Int Immunol
1998
10
1969
1980
10.1093/intimm/10.12.1969

9885918


48.
Rocken
M

Shevach
EM


Immune deviation-the third dimension of nondeletional T cell tolerance
Immunol Rev
1996
149
175
194
10.1111/j.1600-065X.1996.tb00904.x

9005214


49.
Erdmann
AA

Gao
ZG

Jung
U

Foley
J

Borenstein
T

Jacobson
KA

Fowler
DH


Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo
Blood
2005
105
4707
4714
10.1182/blood-2004-04-1407

15746085


50.
Linden
J


Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection
Annu Rev Pharmacol Toxicol
2001
41
775
787
10.1146/annurev.pharmtox.41.1.775

11264476



Abbreviations
ACR
apyrase conserved regions


ATPDase
ATP diphosphohydrolase


DC
dendritic cell


EC
endothelial cell


E-NTPDase
ecto-nucleoside triphosphate diphosphohydrolase


IL
interleukin


LC
Langerhans cells


NPP
nucleotide pyrophosphatase/phosphodiesterase


Treg
T regulatory cells






